Small Interference RNAs (siRNAs)
Research in the Area of Small Interference RNAs (siRNAs) Reported from Kanazawa University
Published in Gene Therapy Weekly, February 16th, 2012
"Pharmaceutical research center. None. Not applicable. TLR4 in the immortalized progesterone receptor-expressing human endometrial epithelial cell line, EM-PR, was activated with lipopolysaccharide and high-mobility group box 1 (LPS/HMGB1) in the presence or absence of the synthetic progestin dienogest or endogenous progesterone. The production of interleukin (IL)-8, IL-6, and monocyte chemoattractant protein...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2012-02-16)
More Articles from Gene Therapy Weekly
- HIV/AIDS
Viral Genetics Inc. Issues 2011 Year in Review and 2012 Outlook - Clinical Trial Research
U.S. Food And Drug Administration Approves Pfizer's INLYTA(R) axitinib For Patients With Previously Treated Advanced Renal Cell Carcinoma RCC - Biotechnology
Studies from University of Milan Yield New Data on Biotechnology - Serous Carcinoma
Studies from Laboratory of Cell Biology Further Understanding of Serous Carcinoma - Colon Cancer
Researchers from Graduate School of Medicine Describe Findings in Colon Cancer - Wilms' Tumor
Research on Wilms' Tumor Reported by Investigators at Osaka University - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
